Annual CFF
$5.01 M
+$4.97 M+11823.81%
31 December 2023
Summary:
RenovoRx annual cash flow from financing activities is currently $5.01 million, with the most recent change of +$4.97 million (+11823.81%) on 31 December 2023. During the last 3 years, it has risen by +$1.81 million (+56.55%). RNXT annual CFF is now -74.09% below its all-time high of $19.33 million, reached on 31 December 2021.RNXT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$15.00 K
-$9.63 M-99.84%
30 September 2024
Summary:
RenovoRx quarterly cash flow from financing activities is currently $15.00 thousand, with the most recent change of -$9.63 million (-99.84%) on 30 September 2024. Over the past year, it has increased by +$15.00 thousand (+100.00%). RNXT quarterly CFF is now -99.91% below its all-time high of $17.29 million, reached on 30 September 2021.RNXT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$15.09 M
+$15.00 K+0.10%
30 September 2024
Summary:
RenovoRx TTM cash flow from financing activities is currently $15.09 million, with the most recent change of +$15.00 thousand (+0.10%) on 30 September 2024. Over the past year, it has increased by +$10.07 million (+201.04%). RNXT TTM CFF is now -23.64% below its all-time high of $19.76 million, reached on 30 September 2021.RNXT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNXT Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | +100.0% | +201.0% |
| 3 y3 years | +56.5% | -99.9% | -23.6% |
| 5 y5 years | - | - | - |
RNXT Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -74.1% | >+9999.0% | -99.9% | -23.6% | >+9999.0% | |
| 5 y | 5 years | -74.1% | -99.9% | -23.6% | >+9999.0% | ||
| alltime | all time | -74.1% | -99.9% | -23.6% | >+9999.0% |
RenovoRx Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $15.00 K(-99.8%) | $15.09 M(+0.1%) |
| June 2024 | - | $9.65 M(+78.0%) | $15.07 M(+44.6%) |
| Mar 2024 | - | $5.42 M(>+9900.0%) | $10.42 M(+108.1%) |
| Dec 2023 | $5.01 M(>+9900.0%) | $0.00(0.0%) | $5.01 M(-0.1%) |
| Sept 2023 | - | $0.00(-100.0%) | $5.01 M(-0.1%) |
| June 2023 | - | $5.00 M(>+9900.0%) | $5.01 M(>+9900.0%) |
| Mar 2023 | - | $6000.00(+100.0%) | $22.00 K(-47.6%) |
| Dec 2022 | $42.00 K | $3000.00(-25.0%) | $42.00 K(-34.4%) |
| Sept 2022 | - | $4000.00(-55.6%) | $64.00 K(-99.6%) |
| June 2022 | - | $9000.00(-65.4%) | $17.35 M(-10.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $26.00 K(+4.0%) | $19.32 M(-0.0%) |
| Dec 2021 | $19.33 M(+504.2%) | $25.00 K(-99.9%) | $19.33 M(-2.2%) |
| Sept 2021 | - | $17.29 M(+772.2%) | $19.76 M(+700.2%) |
| June 2021 | - | $1.98 M(+5729.4%) | $2.47 M(+28.5%) |
| Mar 2021 | - | $34.00 K(-92.5%) | $1.92 M(-39.9%) |
| Dec 2020 | $3.20 M(>+9900.0%) | - | - |
| Dec 2020 | - | $453.00 K(>+9900.0%) | $3.20 M(+16.5%) |
| Sept 2020 | - | $0.00(-100.0%) | $2.75 M(0.0%) |
| June 2020 | - | $1.43 M(+9.3%) | $2.75 M(+109.3%) |
| Mar 2020 | - | $1.31 M | $1.31 M |
| Dec 2019 | $0.00 | - | - |
FAQ
- What is RenovoRx annual cash flow from financing activities?
- What is the all time high annual CFF for RenovoRx?
- What is RenovoRx annual CFF year-on-year change?
- What is RenovoRx quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for RenovoRx?
- What is RenovoRx quarterly CFF year-on-year change?
- What is RenovoRx TTM cash flow from financing activities?
- What is the all time high TTM CFF for RenovoRx?
- What is RenovoRx TTM CFF year-on-year change?
What is RenovoRx annual cash flow from financing activities?
The current annual CFF of RNXT is $5.01 M
What is the all time high annual CFF for RenovoRx?
RenovoRx all-time high annual cash flow from financing activities is $19.33 M
What is RenovoRx annual CFF year-on-year change?
Over the past year, RNXT annual cash flow from financing activities has changed by +$4.97 M (+11823.81%)
What is RenovoRx quarterly cash flow from financing activities?
The current quarterly CFF of RNXT is $15.00 K
What is the all time high quarterly CFF for RenovoRx?
RenovoRx all-time high quarterly cash flow from financing activities is $17.29 M
What is RenovoRx quarterly CFF year-on-year change?
Over the past year, RNXT quarterly cash flow from financing activities has changed by +$15.00 K (+100.00%)
What is RenovoRx TTM cash flow from financing activities?
The current TTM CFF of RNXT is $15.09 M
What is the all time high TTM CFF for RenovoRx?
RenovoRx all-time high TTM cash flow from financing activities is $19.76 M
What is RenovoRx TTM CFF year-on-year change?
Over the past year, RNXT TTM cash flow from financing activities has changed by +$10.07 M (+201.04%)